Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,236 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates PC NAHOA Prescott, Arizona, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
View all 250 locations
View Trial Details
Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Start Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • Dana-Farber/Massachusetts General Hospital, Inc Boston, Massachusetts, United States
  • New Experimental Therapeutics of San Antonio LLC San Antonio, Texas, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

NCT06662786

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • CBCC Global Research Bakersfield, California, United States
View all 237 locations
View Trial Details
Recruiting

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

NCT07107230

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center Herbert Irving Pavilion New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • NEXT Oncology Fairfax, Virginia, United States
View Trial Details
Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

NCT07228832

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Clinical Study Site Mobile, Alabama, United States
  • Clinical Study Site Tuscaloosa, Alabama, United States
  • Clinical Study Site Goodyear, Arizona, United States
  • Clinical Study Site Beverly Hills, California, United States
View all 140 locations
View Trial Details
Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT06710756

Conditions
Adenoma, Adnexal Diseases, Colonic Diseases, +39 more
Locations
  • University of Miami Miami, Florida, United States
  • Biogenix Miami, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View Trial Details
Recruiting

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

NCT05379595

Conditions
Advanced or Metastatic Colorectal Cancer, Colonic Diseases, Colorectal Neoplasms, +9 more
Locations
  • O Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, Los Angeles UCLA Los Angeles, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 53 locations
View Trial Details

Related conditions